tiprankstipranks
Trending News
More News >
Adagio Medical Holdings (ADGM)
NASDAQ:ADGM
US Market

Adagio Medical Holdings (ADGM) Ratios

Compare
42 Followers

Adagio Medical Holdings Ratios

ADGM's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, ADGM's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.84 0.11 0.02 0.15
Quick Ratio
0.68 0.04 -0.04 0.09
Cash Ratio
0.48 0.03 0.01 0.08
Solvency Ratio
-2.24 -0.77 -0.11 -0.59
Operating Cash Flow Ratio
-2.27 -0.53 -0.08 -0.18
Short-Term Operating Cash Flow Coverage
-122.15 -0.65 -4.04 0.00
Net Current Asset Value
$ -24.71M$ -43.75M$ -8.74M$ -10.35M
Leverage Ratios
Debt-to-Assets Ratio
0.70 5.85 <0.01 0.00
Debt-to-Equity Ratio
-16.74 -0.95 <0.01 0.00
Debt-to-Capital Ratio
1.06 -18.54 <0.01 0.00
Long-Term Debt-to-Capital Ratio
1.06 >-0.01 0.00 0.00
Financial Leverage Ratio
-24.04 -0.16 1.06 1.08
Debt Service Coverage Ratio
-99.45 -0.66 -91.12 0.00
Interest Coverage Ratio
-108.40 -16.84 -7.37 0.00
Debt to Market Cap
1.79 0.56 <0.01 0.00
Interest Debt Per Share
1.47 5.30 0.01 0.00
Net Debt to EBITDA
-0.24 -1.41 >-0.01 0.03
Profitability Margins
Gross Profit Margin
746.85%-335.33%-362.96%-328.89%
EBIT Margin
46837.06%-9314.00%-12452.91%-7384.44%
EBITDA Margin
50162.24%-9136.67%-12390.48%-7260.00%
Operating Profit Margin
47985.50%-9314.00%-533.90%-2449.71%
Pretax Profit Margin
50658.15%-12715.33%564.81%-2430.32%
Net Profit Margin
52154.80%-12715.33%564.81%-2430.32%
Continuous Operations Profit Margin
48272.03%-12715.33%564.81%-2430.32%
Net Income Per EBT
102.95%100.00%100.00%100.00%
EBT Per EBIT
105.57%136.52%-105.79%99.21%
Return on Assets (ROA)
-236.42%-558.92%0.70%-4.36%
Return on Equity (ROE)
-752.11%90.59%0.75%-4.71%
Return on Capital Employed (ROCE)
-314.13%66.68%-0.69%-4.58%
Return on Invested Capital (ROIC)
-350.81%1301.44%-0.69%-4.58%
Return on Tangible Assets
-702.93%-558.92%0.70%-4.36%
Earnings Yield
-600.69%-53.66%0.61%-3.78%
Efficiency Ratios
Receivables Turnover
0.00 4.23 -0.03 8.18
Payables Turnover
0.90 0.34 0.87 2.00
Inventory Turnover
0.60 0.39 2.38 3.47
Fixed Asset Turnover
-0.06 0.19 0.10 0.16
Asset Turnover
>-0.01 0.04 <0.01 <0.01
Working Capital Turnover Ratio
-0.05 -0.01 -0.03 -0.10
Cash Conversion Cycle
206.77 -55.59 -12.99K -32.30
Days of Sales Outstanding
0.00 86.38 -12.72K 44.61
Days of Inventory Outstanding
610.83 928.43 153.09 105.28
Days of Payables Outstanding
404.06 1.07K 421.73 182.18
Operating Cycle
610.83 1.01K -12.57K 149.89
Cash Flow Ratios
Operating Cash Flow Per Share
-1.43 -3.27 -0.03 -0.06
Free Cash Flow Per Share
-1.02 -3.31 -0.05 -0.12
CapEx Per Share
0.06 0.04 0.03 0.07
Free Cash Flow to Operating Cash Flow
0.72 1.01 2.03 2.19
Dividend Paid and CapEx Coverage Ratio
-25.42 -75.45 -0.97 -0.84
Capital Expenditure Coverage Ratio
-25.42 -75.45 -0.97 -0.84
Operating Cash Flow Coverage Ratio
-1.00 -0.64 -4.04 0.00
Operating Cash Flow to Sales Ratio
153.76 -85.51 -2.57 -3.96
Free Cash Flow Yield
-128.11%-36.56%-0.57%-1.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.17 -1.86 162.66 -26.46
Price-to-Sales (P/S) Ratio
-85.93 236.98 918.72 643.10
Price-to-Book (P/B) Ratio
-9.46 -1.69 1.22 1.25
Price-to-Free Cash Flow (P/FCF) Ratio
-0.78 -2.74 -175.89 -74.14
Price-to-Operating Cash Flow Ratio
-0.56 -2.77 -357.87 -162.26
Price-to-Earnings Growth (PEG) Ratio
0.02 <0.01 -1.40 >-0.01
Price-to-Fair Value
-9.46 -1.69 1.22 1.25
Enterprise Value Multiple
-0.41 -4.00 -7.42 -8.83
Enterprise Value
29.58M 109.67M 173.67M 173.14M
EV to EBITDA
-0.41 -4.00 -7.42 -8.83
EV to Sales
-206.86 365.55 918.87 641.25
EV to Free Cash Flow
-1.88 -4.22 -175.92 -73.92
EV to Operating Cash Flow
-1.35 -4.28 -357.93 -161.79
Tangible Book Value Per Share
-1.45 -5.36 7.45 7.26
Shareholders’ Equity Per Share
-0.09 -5.36 7.45 7.26
Tax and Other Ratios
Effective Tax Rate
-0.13 0.00 0.00 0.00
Revenue Per Share
>-0.01 0.04 <0.01 0.01
Net Income Per Share
-4.85 -4.86 0.06 -0.34
Tax Burden
1.03 1.00 1.00 1.00
Interest Burden
1.08 1.37 -0.05 0.33
Research & Development to Revenue
-82.66 51.33 94.47 56.87
SG&A to Revenue
-4.28 15.84 5.34 24.50
Stock-Based Compensation to Revenue
-7.06 1.47 1.93 1.26
Income Quality
0.28 0.67 -0.45 0.16
Currency in USD